Influencing patient safety through the wide distribution of electronic Product Information
In a world where we are increasingly bombarded with an abundance of content, it has never been more challenging to engage effectively with prescribers and patients.
A change is on the horizon - how we distribute medicines’ electronic Product Information (ePI) and embed it within healthcare systems is pivotal to enabling pharma to more effectively communicate with their audience, and improve medication adherence and patient safety.
Join us for an exciting day with leading industry experts to examine how changes to the distribution of digital medicines information will impact Regulatory Affairs, Med Info and Commercial Pharma.
*This event is for Datapharm customers only.
9:00am Doors open
9:20 – 9:30am
Rich Cooper, CEO, Datapharm
9:30 – 10:10am
Shaping the ABPI Code
From the use of web links and adverse event reporting to innovative use of QR codes, digital is now a part of everyday life for Pharma in its efforts to engage with HCPs and patients.
With the 2024 Code on the horizon, Alex Fell gives an indication of the likely changes coming which will provide further clarity and modernisation to the Code. You will also learn how Pharma can help build a transparent environment which supports compliance and safety.
Alex Fell, Director, PMCPA
10:15 – 10:35am
Managing healthcare product information can be smoother sailing: How Datapharm caters to the needs of Pharma
The life of a Pharma company is seldom straightforward. Publishing medicines information means every attention to detail matters so that compliance, regulation and, most importantly, patient safety are not compromised.
Our Customer Success team has plenty of experience looking after customers of all sizes and specialisms to make sure their lives are as stress-free as possible. Hear from our Customer Success Manager as she speaks on the variety of challenges facing Pharma with their medicine information today, and the unique solutions which can be adopted.
Jennifer Dunne, Head of Customer Success, Datapharm
10:40 – 11:15am
Transforming the patient experience through improved use of electronic Product Information
The capabilities of ePI (electronic Product Information) bring huge potential to improve patient outcomes around the world. Globally, the move to a new standard for ePI will make medicines information more easily accessible. It will allow better interoperability between systems, meaning that information flows more easily between Pharma, Regulators and Healthcare.
Learn about the future made possible by ePI, and how the upgraded emc publisher, due for release in late 2023, will support Pharma in their readiness.
Matthew Main, Product Manager, Datapharm
Philippe Michiels, Principal Architect, Datapharm
11:15 – 11:45am
11:45am – 12:15pm
Your audience’s search for information on emc: the new era of engagement
emc has a prominent role to play in the HCP’s medical information journey. But how much do you know about how they search for and consume this information?
In this session, we look at how different audiences access information online, how they use emc and what they find most important about their source of information.
You will also hear first-hand from Sadiya Motorwala, a former NHS HCP, on how medicines information is used in the healthcare setting.
John Moreland, Product manager, emc
Sadiya Motorwala, Data Quality Lead, Datapharm
12:20 – 12:50pm
Prescribing in the Digital Age: what is the future of healthcare and Prescribing Information?
In an age where information is changing at a rapid rate, there is a breadth of challenges Pharma faces with managing PI, but also a range of opportunities.
Our expert panel discusses how to approach PI management, the difficulties with physical PI and outsourcing PI creation, and how to take advantage of digital methods such as QR codes.
Richard Blackwell, Medical Community Lead, Roche
Clare Hendry, Medical Capabilities Manager, Takeda
Daksha Sachdev, Director, MediCom Solutions LTD
01:05 – 1:35pm
Lunch & Learn Roundtables
Exclusive for this year's event, we are inviting customers to take part in optional roundtable discussions on some of the industry's most poignant topics.
We will be discussing the use of electronic Product Information and non-promotional medical content, both in the context of medicines information.
There are two tables, each with 8 places. Seats will be allocated on a 'first come first served' basis.
If you would like to learn more about this session, please contact our team at [email protected].
1:40 – 2:10pm
How Datapharm enhances patient safety through the distribution of your product information
Once Pharma has published its product information on emc or the dm+d database, it is fed through the UK healthcare ecosystem, which includes multiple publications, websites and healthcare IT systems.
During this session, you will learn how your information flows through to different healthcare systems, the ways it is used and how it is consumed by prescribers and patients.
Adam Smith, Director (Data), Datapharm
2:15 – 2:40pm
Answering HCPs’ frequently asked questions through the SRD pilot on emc: the results and lessons learned
At the beginning of 2023, MILE and Datapharm brought together four major pharmaceutical companies to pilot a new feature on emc which provides access to self-service SRDs (Scientific Response Documents). The feature enables HCPs to find answers to frequently asked questions which are not directly covered within the SmPC.
Following the conclusion of the pilot, we look at how the new SRD feature benefits both Pharma and Healthcare, lessons learnt from the pilot and the role this service will be able to play in supporting clinical decisions in the healthcare setting.
Helen Surrey, Communications Lead, MILE (Medical Information Leaders in Europe)
2:50 – 3:20pm
Exclusive update from the UK electronic Patient Information taskforce: the goals and progress made so far
The UK electronic Patient Information taskforce has brought together hard-working leaders within the Pharma industry to support the industry and result in better patient outcomes through digital use of medicine product information.
In this session you will hear from the people at the centre of this project on why this is so important to the industry, the progress which is being made and what this looks like for Pharma in the near future.
Representatives of the UK taskforce:
Smita Robinson, Director, Pfizer
Michael Clarke, Partnerships Director, BGMA
3:20 – 3:30pm
Final remarks from Datapharm's CEO
Rich Cooper, CEO, Datapharm
3:30 – 4:30pm
Due to popular demand from customers, we have opened up the event with extended time for networking.
Meet, greet and make the most of this invaluable opportunity for discussions with your Pharma peers at a pivotal time for healthcare information.